DOI : 10.1055/s-00000134

Diabetologie und Stoffwechsel

Issue S 01 · Volume 19 · April 2024 DOI: 10.1055/s-014-59530


Diabetes. Umwelt. Leben. Perspektiven aus allen Blickwinkeln
CityCube Berlin, 08.–11.05.2024

Kongresspräsident: Prof. Dr. med. Baptist Gallwitz, Tübingen
Kongresssekretärin: Prof. Dr. rer. nat. Cora Weigert, Tübingen
Abstracts (HTML) Abstracts (PDF) List of Authors
P13.01
Seidel, Ute; Bergenstal, Richard; Watt, Sara; Matos, Ana Laura; Lingvay, Ildiko; Mader, Julia K.; Nishida, Tomoyuki; Rosenstock, Julio: CGM outcomes and hypoglycemia duration with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naïve T2D: ONWARDS 1 exploratory analysis
P13.02
Kellerer, Monika; Bajaj, Harpreet Singh; Ásbjörnsdóttir, Björg; Carstensen, Lisbeth; Lehrskov, Lars Lang; Mathieu, Chantal; Philis-Tsimikas, Athena; Battelino, Tadej: Similar hypoglycemia duration with once-weekly icodec versus degludec or glargine U100 in insulin-treated T2D: a post hoc CGM analysis from ONWARDS 2 & 4
P13.03
Nicola, Birgit; Hingst, Janne Rasmus; Cieslarova, Blanka; Donatsky, Anders Meller; Joseph, Josmin Rose; Kupčová, Viera; Haahr, Hanne: The effect of various degrees of hepatic impairment on the pharmacokinetic characteristics of once-weekly insulin icodec
P13.04
Westrup, Dagmar; Haahr, Hanne; Kristensen, Nils Rode; Larsen, Jonas; Wagner, Frank; Ignatenko, Stanislav: Pharmacokinetic properties of once-weekly insulin icodec in individuals with renal impairment versus normal renal function
P13.05
Kazda, Christof; Bue-Valleskey, Juliana; Zhang, Qianyi; Haupt, Axel; Frias, Juan; Dahl, Dominik; Segner, Alexander: Once Weekly (QW) Insulin Efsitora alfa (Efsitora) and Daily Degludec (DEG) Achieve Comparable Glycemic Control in 3 Patient Populations Studied During Phase 2: Clinical Insights from CGM Assessments
P13.06
Bue-Valleskey, Juliana; Kazda, Christof; Zhang, Qianyi; Haupt, Axel; Dahl, Dominik; Frias, Juan; Liebl, Andreas: Initiation of Once Weekly (QW) Insulin Efsitora alfa (efsitora) in 3 Patient Populations in Phase 2 Studies Using a One-time Loading Dose (LD) Minimizes Transient Hyperglycemia and is not Associated with Excess Hypoglycemia Risk vs Degludec
P13.07
Katzenstein, Sarah; Sandforth, Arvid; Minelli-Faiao, Vitória; Sandforth, Leontine; Schick, Fritz; Machann, Jürgen; Preißl, Hubert; Peter, Andreas; Seissler, Jochen; Hauner, Hans; Perakakis, Nikolaos; Schürmann, Annette; Pfeiffer, Andreas F.H.; Kabisch, Stefan; Blüher, Matthias; Szendrödi, Julia; Solimena, Michele; de Angelis, Martin Hrabě; Bornstein, Stefan; Fritsche, Andreas; Wagner, Robert; Roden, Michael; Stefan, Norbert; von Schwartzenberg, Reiner Jumpertz; Birkenfeld, Andreas L.: Remissionsraten nach Lebensstilintervention in spezifischen Hoch-Risiko Prädiabetes-Clustern